Results 161 to 170 of about 26,042 (243)

Successful treatment of metastatic dermatofibrosarcoma protuberans of the breast to the lungs with imatinib mesylate: a case report. [PDF]

Ecancermedicalscience
Kpatsi S, Daniels J, Kyei KA, Vanderpuye V.   +3 more
europepmc   +1 more source

Imatinib Mesylate-Induced Acquired Dermal Melanocytosis and Acquired Bilateral Nevus of Ota-Like Macules. [PDF]

Ann Dermatol, 2021
Jang JW, Song CH, Jung YJ, Cheon DU, Koh WS, Ro YS, Ko JY.   +6 more
europepmc   +1 more source

Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature [PDF]

, 2014

core   +1 more source

Compatibility Studies of Different Crystal Forms of Imatinib Mesylate with Pharmaceutical Excipients. [PDF]

ACS Omega
Mou Y, Zhao Y, Wen S, Li X, Zhang W, Xu X, Wang Y.   +6 more
europepmc   +1 more source

Supplementary files: The association between FOXO3a rs4946936 gene polymorphism and the levels of FOXO3a among chronic granulocytic leukemia patients treated with imatinib mesylate

, 2021
Jonny Karunia Fajar
openalex   +1 more source

Claudin-1 Contributes to Gastrointestinal Stromal Tumors (GIST) Resistance to Imatinib Mesylate (IM) via Regulation of FGFR-Signaling. [PDF]

Int J Mol Sci
Boichuk S, Bikinieva F, Dunaev P, Galembikova A, Mikheeva E, Valeeva E, Mani S, Khromova N, Kopnin P, Shigapova L, Deviatiiarov R, Shagimardanova E, Ryzhkin S, Sabirov A.   +13 more
europepmc   +1 more source

In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models. [PDF]

Transl Vis Sci Technol, 2021
Baek YY, Sung B, Choi JS, Go HK, Kim DH, Hyon JY, You JC.   +6 more
europepmc   +1 more source

Imatinib mesylate promotes melanogenesis through the modulation of p38 and MITF in murine cells. [PDF]

Toxicol Res
Talapphet N, Kim MM.
europepmc   +1 more source

Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. [PDF]

, 2008
Jimenez, Sergio A., Rosenbloom, Joel
core   +1 more source

Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome. [PDF]

Br J Haematol
Kim DH, Kim S, Park S, Byun JM, Hong J, Shin DY, Kim I, Bang SM, Lee JO, Lee JY, Kim SA, Kim KH, Chung YJ, Jung SH, Koh Y, Yoon SS.   +15 more
europepmc   +1 more source